NeoGenomics, Inc. (NEO)

Healthcare · Diagnostics Research · NASDAQ

NeoGenomics, Inc. (NEO) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $2.43B, a trailing price-to-earnings ratio of 125.9 and a free-cash-flow yield of -0.9%. Over the most recent reported fiscal year, revenue grew 10.1%.

Market cap	$2.43B
Trailing P/E	125.9
FCF yield	-0.9%
Revenue growth (YoY)	+10.1%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Diagnostics Research

Explore live NEO data on Nama Insights →

Recent Congressional trades

NeoGenomics, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Sep 10, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Jun 6, 2025